* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Nimotop (nimodipine) is a prescription medication used to help improve neurological outcomes in patients who have experienced a subarachnoid hemorrhage (SAH) caused by a ruptured brain aneurysm.
A subarachnoid hemorrhage is a serious type of bleeding that occurs in the space surrounding the brain. One of the major complications following this condition is cerebral vasospasm, a narrowing of the brain’s blood vessels that can reduce blood flow and lead to further brain injury.
Nimotop is indicated for patients with subarachnoid hemorrhage resulting from ruptured intracranial berry aneurysms.
The medication is used to:
Nimotop may be used regardless of a patient’s neurological condition following the hemorrhage.
Nimotop belongs to a class of medications known as calcium channel blockers.
It works by blocking the movement of calcium into smooth muscle cells within blood vessel walls. This action helps relax and widen blood vessels, particularly those supplying the brain.
By improving blood flow to brain tissue, Nimotop helps:
When used as prescribed, Nimotop may help:
Nimotop is used to help reduce complications associated with subarachnoid hemorrhage, but it does not repair the ruptured aneurysm itself. Other treatments, such as surgery or endovascular procedures, may be required to manage the underlying cause of the bleeding.
Because subarachnoid hemorrhage is a serious medical emergency, Nimotop is typically administered under close medical supervision, with ongoing monitoring to ensure the medication remains safe and effective throughout treatment.
Nimotop is available in tablet or capsule form and should be started as soon as possible after a subarachnoid hemorrhage (SAH), ideally within 96 hours (4 days) of diagnosis. Early treatment helps reduce the risk of complications caused by decreased blood flow to the brain.
Take Nimotop exactly as prescribed by your healthcare provider. The medication is typically taken every 4 hours and should be swallowed with a full glass of water (240 mL or 8 ounces). After taking a dose, avoid lying down for at least 10 minutes unless otherwise directed by your healthcare provider.
For most adults with subarachnoid hemorrhage, the recommended dose is:
Your healthcare provider may adjust your treatment plan based on your individual medical condition and response to therapy.
Avoid consuming grapefruit or grapefruit juice while taking Nimotop. Grapefruit products can increase the amount of nimodipine in your bloodstream, which may raise the risk of side effects such as low blood pressure, dizziness, or fainting.
Be sure to inform your healthcare provider about all medications, vitamins, and supplements you take, as certain medications may interact with Nimotop.
Regular monitoring may be required during treatment to assess your response to therapy and check for potential side effects. Take Nimotop exactly as directed and contact your healthcare provider if you have any questions or concerns about your treatment plan.
Nimotop (Nimodipine) is available in the following forms and strength:
Before taking Nimotop, discuss your medical history and all medications you take with your healthcare provider. Careful monitoring may be required during treatment to help ensure the medication remains safe and effective.
Nimotop is intended for oral use only and should never be administered by injection or other parenteral routes. Using the medication incorrectly can result in serious complications.
Nimotop can lower blood pressure by relaxing blood vessels. Patients who already have low blood pressure (hypotension) may be at a higher risk of side effects.
Symptoms of low blood pressure may include:
Your healthcare provider may monitor your blood pressure regularly during treatment to ensure it remains within a safe range.
Nimotop may interact with other medications, which can affect how the medication works or increase the risk of side effects.
Before starting treatment, tell your healthcare provider about all products you use, including:
Do not start, stop, or change any medication without consulting your healthcare provider.
Avoid consuming grapefruit or grapefruit juice while taking Nimotop. Grapefruit products can increase the amount of nimodipine in the bloodstream, which may raise the risk of side effects such as:
Nimotop may cause:
Until you know how the medication affects you, use caution when:
If you feel dizzy or faint, avoid these activities and contact your healthcare provider if symptoms persist.
Although uncommon, Nimotop may cause serious allergic reactions.
Seek immediate medical attention if you experience:
These symptoms may indicate a serious reaction that requires urgent medical care.
Regular monitoring and follow-up appointments can help ensure Nimotop remains a safe and effective part of your treatment plan following subarachnoid hemorrhage.
For optimal absorption, Nimotop (nimodipine) should be taken at least 1 hour before a meal or 2 hours after a meal. Taking the medication on an empty stomach helps ensure consistent absorption and effectiveness. Always follow the dosing schedule provided by your healthcare provider.
No. Nimotop is specifically indicated for improving neurological outcomes and reducing ischemic complications following subarachnoid hemorrhage (SAH) caused by a ruptured brain aneurysm. It is not approved for the prevention of strokes or for the treatment or prevention of other medical conditions unless specifically directed by a healthcare provider.
The time it takes for Nimotop to produce noticeable benefits can vary from person to person. Several factors may influence how quickly the medication works, including the severity of the condition being treated, how soon treatment is started after the hemorrhage, the prescribed dosage, and the individual’s overall response to therapy. Because Nimotop is used to help reduce complications associated with subarachnoid hemorrhage, its benefits may not be immediately noticeable. Your healthcare team will closely monitor your condition throughout treatment to assess your response and ensure the medication is working safely and effectively.
No. Nimotop is generally best taken on an empty stomach, at least 1 hour before eating or 2 hours after a meal. Taking it with food may affect how the medication is absorbed by the body. Follow your healthcare provider’s instructions carefully to achieve the best treatment results.
| Generic name: | Nimodipine |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 30mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Nimotop (nimodipine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time. This quantity is often recommended for medications prescribed for the management of chronic conditions, ensuring patients have an adequate supply without the need for frequent refills.
Here’s what you need to know:
Dosage and Quantity: Nimotop is commonly prescribed in dosages of 30 mg tablets, taken every 4 hours or as directed by your healthcare provider. For a 90-day supply, if you are prescribed to take one tablet every 4 hours, you would typically order 540 tablets (90 days x 6 tablets per day).
Yes, we do sell nimodipine on our website. You can enjoy low prices and convenient ordering options. However, please note that you will need a valid prescription from your healthcare provider in order to purchase nimodipine from us. We require this prescription to dispense the medication safely and in compliance with regulatory guidelines. You can submit your prescription by mail, fax, or upload it through your online account during the ordering process.
Yes, we ship Nimotop (nimodipine) to both the United States and Puerto Rico.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Nimotop (Nimodipine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Nimotop (Nimodipine).
REVIEWS